We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAC.U
4126
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$10K ﹤0.01%
992
ELYS
4127
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$10K ﹤0.01%
35,013
+8,343
+31% +$2.28K
GENY
4128
DELISTED
Principal Exchange-Traded Funds Principal Millennial Global Growth ETF
GENY
$10K ﹤0.01%
248
-138
-36% -$5.04K
CGRN
4129
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$10K ﹤0.01%
+6,724
New +$11.6K
BRDS
4130
DELISTED
Bird Global, Inc.
BRDS
$10K ﹤0.01%
2,286
+1,161
+103% +$8.52K
LFLY
4131
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$10K ﹤0.01%
753
+72
+11% +$1.05K
HARP
4132
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$10K ﹤0.01%
1,389
+842
+154% +$7.09K
ILLM
4133
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$10K ﹤0.01%
6,402
+2,264
+55% +$3.73K
RUTH
4134
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$10K ﹤0.01%
661
-1,686
-72% -$29.6K
LMST
4135
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
$10K ﹤0.01%
406
+380
+1,462% +$9.1K
CDAK
4136
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$10K ﹤0.01%
25,662
+19,089
+290% +$12.6K
VLDR
4137
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$10K ﹤0.01%
14,377
+7,703
+115% +$7.28K
ELAT
4138
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
$10K ﹤0.01%
505
+463
+1,102% +$9.31K
RBCN
4139
DELISTED
Rubicon Technology, Inc.
RBCN
$10K ﹤0.01%
5,863
+626
+12% +$1.18K
ARCH
4140
DELISTED
Arch Resources, Inc.
ARCH
$10K ﹤0.01%
70
-2,172
-97% -$318K
RHE
4141
DELISTED
Regional Health Properties, Inc.
RHE
$10K ﹤0.01%
2,937
+1,759
+149% +$4.66K
ATIP
4142
DELISTED
ATI Physical Therapy, Inc.
ATIP
$10K ﹤0.01%
670
+450
+205% +$15.2K
CORS.U
4143
DELISTED
Corsair Partnering Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CORS.U
$10K ﹤0.01%
1,072
+100
+10% +$990
PLM
4144
DELISTED
PolyMet Mining Corp.
PLM
$10K ﹤0.01%
3,820
+221
+6% +$636
INTZ
4145
DELISTED
INTRUSION INC NEW
INTZ
$10K ﹤0.01%
3,067
-2,472
-45% -$8.06K
ABVC icon
4146
ABVC BioPharma
ABVC
$23.5M
$9K ﹤0.01%
1,425
-85
-6% -$628
ACHR icon
4147
Archer Aviation
ACHR
$5.06B
$9K ﹤0.01%
4,772
-8,174
-63% -$20.2K
ACIC icon
4148
American Coastal Insurance
ACIC
$466M
$9K ﹤0.01%
8,174
+5,349
+189% +$2.56K
ACNT icon
4149
Ascent Industries
ACNT
$135M
$9K ﹤0.01%
1,037
+426
+70% +$5.14K
AIFA
4150
All In FutureTech Alliance Inc
AIFA
$19.5M
$9K ﹤0.01%
1,376
+203
+17% +$1.4K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.